D.C. Doval

812 total citations
39 papers, 533 citations indexed

About

D.C. Doval is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Cancer Research. According to data from OpenAlex, D.C. Doval has authored 39 papers receiving a total of 533 indexed citations (citations by other indexed papers that have themselves been cited), including 22 papers in Pulmonary and Respiratory Medicine, 16 papers in Oncology and 13 papers in Cancer Research. Recurrent topics in D.C. Doval's work include Lung Cancer Treatments and Mutations (11 papers), Cancer Genomics and Diagnostics (8 papers) and Cancer Treatment and Pharmacology (4 papers). D.C. Doval is often cited by papers focused on Lung Cancer Treatments and Mutations (11 papers), Cancer Genomics and Diagnostics (8 papers) and Cancer Treatment and Pharmacology (4 papers). D.C. Doval collaborates with scholars based in India, United States and Spain. D.C. Doval's co-authors include Spiros Mancoridis, Brian S. Mitchell, P. P. Bapsy, P.K. Julka, Sanjay Gupta, G.K. Rath, H. S. Randhawa, Geetashree Mukherjee, V. Kannan and Smita Misra and has published in prestigious journals such as Journal of Clinical Oncology, Cancer Research and Annals of Oncology.

In The Last Decade

D.C. Doval

38 papers receiving 492 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
D.C. Doval India 12 231 155 100 99 76 39 533
Jung Ho Bae South Korea 15 198 0.9× 27 0.2× 244 2.4× 79 0.8× 22 0.3× 55 734
Spyros Potamianos Greece 19 183 0.8× 150 1.0× 70 0.7× 282 2.8× 112 1.5× 50 1.2k
Sofiane Maza Germany 14 146 0.6× 32 0.2× 129 1.3× 81 0.8× 18 0.2× 32 601
Enyi Tang China 14 43 0.2× 14 0.1× 99 1.0× 31 0.3× 58 0.8× 54 541
John Fisher United States 13 114 0.5× 29 0.2× 24 0.2× 11 0.1× 54 0.7× 24 456
Zafar Malik United Kingdom 14 330 1.4× 58 0.4× 116 1.2× 24 0.2× 66 0.9× 57 592
Michael Homer New Zealand 15 70 0.3× 53 0.3× 89 0.9× 122 1.2× 7 0.1× 65 616
William Andersen United States 11 79 0.3× 38 0.2× 37 0.4× 95 1.0× 40 0.5× 20 374
Shifu Li China 11 46 0.2× 111 0.7× 35 0.3× 167 1.7× 101 1.3× 49 528
Wenchao Gu China 18 347 1.5× 25 0.2× 219 2.2× 40 0.4× 330 4.3× 72 963

Countries citing papers authored by D.C. Doval

Since Specialization
Citations

This map shows the geographic impact of D.C. Doval's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by D.C. Doval with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites D.C. Doval more than expected).

Fields of papers citing papers by D.C. Doval

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by D.C. Doval. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by D.C. Doval. The network helps show where D.C. Doval may publish in the future.

Co-authorship network of co-authors of D.C. Doval

This figure shows the co-authorship network connecting the top 25 collaborators of D.C. Doval. A scholar is included among the top collaborators of D.C. Doval based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with D.C. Doval. D.C. Doval is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Somashekhar, S. P., Rajeev Kumar, Krishna Prasad, et al.. (2024). Real-World Evidence of the Impact of CanAssist Breast on Physician’s Decision About the Use of Adjuvant Chemotherapy in Early Breast Cancer. Cureus. 16(12). e75622–e75622. 2 indexed citations
3.
4.
Thiyagarajan, Saravanan, Amit Kumar Verma, K. S. Gopinath, et al.. (2020). Integrating Systems Biology and an Ex Vivo Human Tumor Model Elucidates PD-1 Blockade Response Dynamics. iScience. 23(6). 101229–101229. 7 indexed citations
5.
6.
Doval, D.C., et al.. (2019). Molecularly targeted therapies in non-small cell lung cancer: The evolving role of tyrosine kinase inhibitors. Indian Journal of Cancer. 56(5). 23–23. 11 indexed citations
7.
Doval, D.C., et al.. (2017). Liquid biopsy: A potential and promising diagnostic tool for advanced stage non-small cell lung cancer patients. Indian Journal of Cancer. 54(5). 25–25. 9 indexed citations
8.
9.
10.
Doval, D.C., et al.. (2016). Study of efficacy and safety of modified adjuvant intraperitoneal chemotherapy regimen in carcinoma ovary. Indian Journal of Cancer. 53(4). 607–607. 4 indexed citations
11.
12.
Digumarti, Raghunadharao, et al.. (2014). Phase 1 dose escalation study of rigosertib by 2-, 4-, or 8-hour infusion twice-weekly in patients with advanced cancer. Indian Journal of Cancer. 51(1). 40–40. 3 indexed citations
13.
Gandhi, Jatin, et al.. (2012). Synchronous Embryonal Rhabdomyosarcoma (NOS) of the Mid-oesophagus and Stomach. Journal of Gastrointestinal Cancer. 43(S1). 217–220. 9 indexed citations
14.
Parikh, PM, Sudeep Gupta, Biren Parikh, et al.. (2011). Management of primary and metastatic triple negative breast cancer: Perceptions of oncologists from India. Indian Journal of Cancer. 48(2). 158–158. 4 indexed citations
15.
Julka, P.K., D.C. Doval, Sanjay Gupta, & G.K. Rath. (2008). Response assessment in solid tumours: a comparison of WHO, SWOG and RECIST guidelines. British Journal of Radiology. 81(966). 444–449. 36 indexed citations
16.
Doval, D.C., et al.. (2007). Report of a Case of Pericardial Mesothelioma with Liver Metastases Responding Well to Pemetrexed and Platinum-Based Chemotherapy. Journal of Thoracic Oncology. 2(8). 780–781. 11 indexed citations
17.
Doval, D.C.. (2002). From neurons to consciousness. 38–43.
18.
Doval, D.C., et al.. (1997). Osteosarcoma of the jaw bones. British Journal of Oral and Maxillofacial Surgery. 35(5). 357–362. 57 indexed citations
19.
Srinivasulu, M., et al.. (1994). Adult paratesticular sarcomas: A report of eight cases. Journal of Surgical Oncology. 56(2). 89–93. 11 indexed citations
20.
Chandrashekar, M., et al.. (1990). Neoadjuvant cis‐DDP in esophageal cancers: An experience at a regional cancer centre, India. Journal of Surgical Oncology. 45(3). 173–176. 10 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Jung Ho Bae Breakdown of academic impact, for papers by Spyros Potamianos Breakdown of academic impact, for papers by Sofiane Maza Breakdown of academic impact, for papers by Enyi Tang Breakdown of academic impact, for papers by John Fisher Breakdown of academic impact, for papers by Zafar Malik Breakdown of academic impact, for papers by Michael Homer Breakdown of academic impact, for papers by William Andersen Breakdown of academic impact, for papers by Shifu Li Breakdown of academic impact, for papers by Wenchao Gu
Rankless by CCL
2026